Company news
Ningbo Menovo Pharmaceutical Co., Ltd. Class A (SSE:603538) news
Ningbo Menovo Pharmaceutical Co., Ltd. Class A news releases on 6ix. Latest, Dec 19, 2025: Announcement on CDE’s Technical Review of the Drug Substance…
Press releases — page 2
Announcement on CDE’s Technical Review of the Drug Substance Atorvastatin Calcium by the Holding Subsidiary
December 18, 2025
Announcement on Resolutions of the 21st Meeting of the 5th Board of Directors
December 15, 2025
Announcement on Wholly-owned Subsidiary Obtaining Drug Registration Certificate for Febuxostat Tablets
December 10, 2025
Announcement on Resolutions of the 20th Meeting of the 5th Board of Directors
December 3, 2025
Announcement on Self-exercise Results of Reserved and Granted Portion in the 2nd Exercise Period of the 2021 Stock Option Incentive and Restricted Stock Plan and Share Changes
November 25, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 19, 2025
Announcement on Not Revising Downward Conversion Price of "Menovo Convertible Bonds"
November 12, 2025
Announcement on Resolutions of the 18th Meeting of the 5th Board of Directors
October 27, 2025
Announcement on Wholly-owned Subsidiary Obtaining Drug Registration Certificate for Irbesartan and Hydrochlorothiazide Tablets
October 20, 2025
Announcement on Resolutions of the 17th Meeting of the 5th Board of Directors
October 17, 2025